The role of SGLT-2 inhibitors in the treatment of acute decompensation of chronic heart failure: a meta-analysis of large clinical trials

Omarov O.M., Arabidze G.G.

ABSTRACT

We present a systematic review and meta-analysis of the literature data from the studies conducted to determine the effect of early (up to 24 hours) administration of SGLT2 inhibitors in patients with acute decompensated chronic heart failure on immediate outcomes and the effect of the therapy on reducing levels of inpatient heart failure markers.

Keywords: sodium-glucose transport protein 2 inhibitors, acute decompensation of chronic heart failure

For citation:

Omarov O.M., Arabidze G.G.  The role of SGLT-2 inhibitors in the treatment of acute decompensation of chronic heart failure: a meta-analysis of large clinical trials. International Journal of Heart and Vascular Diseases. 2023. 11(39):41-48. DOI: 10.24412/2311-1623- 2023-39-50-58